Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$6.1 - $10.41 $403,801 - $689,110
-66,197 Reduced 56.1%
51,800 $361,000
Q1 2024

May 10, 2024

BUY
$7.77 - $10.61 $526,806 - $719,358
67,800 Added 135.07%
117,997 $1.25 Million
Q4 2023

Feb 13, 2024

SELL
$6.53 - $8.23 $336,667 - $424,314
-51,557 Reduced 50.67%
50,197 $404,000
Q3 2023

Nov 13, 2023

BUY
$7.69 - $9.71 $68,441 - $86,419
8,900 Added 9.58%
101,754 $842,000
Q2 2023

Aug 07, 2023

SELL
$5.72 - $8.8 $453,596 - $697,840
-79,300 Reduced 46.06%
92,854 $743,000
Q1 2023

May 11, 2023

BUY
$6.28 - $9.85 $557,036 - $873,695
88,700 Added 106.29%
172,154 $1.39 Million
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $508,234 - $661,790
83,454 New
83,454 $523,000
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $20,032 - $24,048
-800 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$27.43 - $32.7 $125,821 - $149,994
-4,587 Reduced 85.15%
800 $24,000
Q1 2021

May 11, 2021

BUY
$21.37 - $34.38 $61,973 - $99,702
2,900 Added 116.61%
5,387 $171,000
Q4 2020

Feb 11, 2021

SELL
$15.31 - $21.12 $4,792 - $6,610
-313 Reduced 11.18%
2,487 $52,000
Q3 2020

Nov 09, 2020

SELL
$14.88 - $20.13 $342,240 - $462,990
-23,000 Reduced 89.15%
2,800 $43,000
Q2 2020

Aug 12, 2020

BUY
$13.31 - $20.51 $343,398 - $529,158
25,800 New
25,800 $470,000
Q2 2019

Aug 08, 2019

SELL
$20.52 - $26.45 $2.67 Million - $3.44 Million
-129,900 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$20.23 - $26.29 $4.89 Million - $6.35 Million
-241,562 Reduced 65.03%
129,900 $3.21 Million
Q4 2018

Feb 07, 2019

BUY
$17.64 - $28.32 $1.12 Million - $1.8 Million
63,662 Added 20.68%
371,462 $6.87 Million
Q3 2018

Oct 30, 2018

BUY
$20.64 - $25.67 $6.35 Million - $7.9 Million
307,800 New
307,800 $7.9 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.